Startup India Government of India
Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹3.36 Lakh
▲ 96% YoY
Net profit · FY 2024
₹40,841
Net margin 12.2%
EBITDA · FY 2024
₹42,536
EBITDA margin 12.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Molekules Pharmaceutical Private Limited
Data last updated:
Molekules Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC370762. Its GSTIN is 09AAPCM1442A1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vipin Kumar and Pradeep Kumar.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nr Bk 31/32 Ulhasnagar, Mumbai, Maharashtra, India – 421002.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.36 Lakh, a growth of 96% compared to the previous year. For the same year it recorded a net profit of ₹40,841 (net margin 12.2%) and EBITDA of ₹42,536 (EBITDA margin 12.7%).
Molekules Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0032567).
Company Details of Molekules Pharmaceutical Private Limited
CIN U51909MH2021PTC370762
Registration Number 370762
Incorporation Date 02 November 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0032567
Recognitions & Rankings of Molekules Pharmaceutical
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-50-0032567
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNr Bk 31/32 Ulhasnagar, Mumbai, Maharashtra, India – 421002
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Molekules Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Molekules Pharmaceutical Private Limited
The main business activity of Molekules Pharmaceutical is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Molekules Pharmaceutical Private Limited FY 2025 filings available
Molekules Pharmaceutical Private Limited reported revenue of ₹3.36 Lakh (up 96% YoY) for FY 2024.
Revenue · FY 2024
₹3.36 Lakh ▲ 96%
Net profit · FY 2024
₹40,841 margin 12.2%
EBITDA · FY 2024
₹42,536 margin 12.7%
Compounded Annual Growth Rate (CAGR) of Molekules Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▲ 96%
EBITDA CAGR growth
1 year
▲ 10%
Revenue rose 96% in the latest year. EBITDA rose 10% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Molekules Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹42,536 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹40,841 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Molekules Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 12.7% | •••• | •••• |
| Net Profit Margin | 12.2% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Molekules Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Kumar | Additional Director | 08 Apr 2024 | 2 Years 6 Months | Current |
| Vipin Kumar Also directs: Wrey Grants Civil Solutions Private Limited | Director | 02 Nov 2021 | 4 Years 11 Months | Current |
Peer Comparison of Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr Bhupendra Super Speciality Hospital Private Limited | ₹3.45 Lakh (FY 2025) | •••• | •••• | •••• | Bhinmal, Rajasthan, India | |
| Onemed Crew Private Limited | ₹3.44 Lakh (FY 2016) | •••• | •••• | •••• | Mohali, Punjab, India | |
| Medics Eduserve Private Limited | ₹3.42 Lakh (FY 2021) | •••• | •••• | •••• | Patna, Bihar, India | |
| Sanvas Pharma Private Limited | ₹3.41 Lakh (FY 2025) | •••• | •••• | 395.0% | •••• | Nagpur, Maharashtra, India |
| Timeless Promise Foundation | ₹3.39 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Gurugram, Haryana, India |
| Molekules Pharmaceutical Private Limited this company | ₹3.36 Lakh (FY 2024) | •••• | •••• | 96.0% | •••• | Mumbai, Maharashtra, India |
| Fishers Health Resort Private Limited | ₹3.34 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Pune, Maharashtra, India |
| Clearcals Private Limited | ₹3.32 Lakh (FY 2024) | •••• | •••• | 404.0% | •••• | Patancheru, Telangana, India |
| Brainberg Knowledge Solutions Private Limited | ₹3.31 Lakh (FY 2025) | •••• | •••• | -99.0% | •••• | Pune, Maharashtra, India |
| United Sindhis International Forum | ₹3.3 Lakh (FY 2025) | •••• | •••• | -76.0% | •••• | Gandhinagar, Gujarat, India |
| RPM Aarogya Hospital Private Limited | ₹3.3 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Molekules Pharmaceutical by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Molekules Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Molekules Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Ashish Kumar Singh ceased to be Director on 10 Apr 2024.
AGM
Molekules Pharmaceutical Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records.
Filing
Molekules Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Ashish Kumar Singh ceased to be Director.
Appointed
Pradeep Kumar was appointed as Additional Director.
Appointed
Vipin Kumar was appointed as Director.
Incorporation
02 Nov 2021
Molekules Pharmaceutical Private Limited was registered on 02 Nov 2021 with Roc Mumbai Ii & aged 4 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Molekules Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Molekules Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Molekules Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAPCM1442A1ZP | Uttar Pradesh | Active | 02 Feb 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Molekules Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molekules Pharmaceutical Private Limited
Molekules Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 November 2021 (5+ years old) and is registered under CIN U51909MH2021PTC370762.
Molekules Pharmaceutical reported revenue of ₹3.36 Lakh for FY 2024 (up 96% YoY).
Molekules Pharmaceutical has 2 current directors:
- Pradeep Kumar - Additional Director
- Vipin Kumar - Director
Molekules Pharmaceutical reported a net profit of ₹40,841 (net margin 12.2%) and EBITDA of ₹42,536 (EBITDA margin 12.7%) for FY 2024, as per its filed financial statements.
The GSTIN of Molekules Pharmaceutical is 09AAPCM1442A1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Molekules Pharmaceutical is U51909MH2021PTC370762. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molekules Pharmaceutical was incorporated on 02 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Molekules Pharmaceutical by revenue are Dr Bhupendra Super Speciality Hospital Private Limited, Onemed Crew Private Limited, Medics Eduserve Private Limited, Sanvas Pharma Private Limited, Timeless Promise Foundation and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Ashish Kumar Singh ceased to be Director on 10 Apr 2024. Pradeep Kumar was appointed as Additional Director on 08 Apr 2024. Vipin Kumar was appointed as Director on 02 Nov 2021.
Yes, Molekules Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Molekules Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0032567).